Factors associated with utilization of dipeptidyl-4 inhibitors in patients with type 2 diabetes mellitus: a cross-sectional retrospective study.

Int J Endocrinol 2014 2;2014:367564. Epub 2014 Sep 2.

Endocrinology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Dipeptidyl-4 (DPP-4) inhibitors are oral antidiabetic agents recently introduced to Malaysia. Thus, limited data is available on their utilization patterns and factors associated with their use. This study aims to analyse the utilization patterns of DPP-4 inhibitors, factors that influenced the choice of agent, and the rationale for treatment with DPP-4 inhibitors in patients with type 2 diabetes mellitus. This retrospective study was conducted to address the utilization pattern of DPP-4 inhibitors and factors that influence choice in type 2 diabetes mellitus patients. 299 subjects taking either sitagliptin or vildagliptin from September 2008 to September 2012 were included in the study. Sitagliptin was more frequently prescribed than vildagliptin. Of the patients prescribed DPP-4 inhibitors, 95% received combinations of these and other agents, whereas only 5% were prescribed DPP-4 inhibitors as monotherapy. Factors affecting the utilization of DPP-4 inhibitors included age (P = 0.049) and concomitant use of beta blockers (P = 0.045) and aspirin (P = 0.008). Early identification of factors associated with DPP-4 inhibitors is essential to enhance quality use of the drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/367564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167207PMC
September 2014
8 Reads

Publication Analysis

Top Keywords

dpp-4 inhibitors
32
type diabetes
12
factors associated
12
diabetes mellitus
12
inhibitors
9
inhibitors factors
8
dpp-4
8
retrospective study
8
utilization patterns
8
prescribed dpp-4
8
patients type
8
inhibitors patients
8
factors
6
utilization
5
september 2012
4
2008 september
4
vildagliptin patients
4
patients prescribed
4
2012 included
4
sitagliptin frequently
4

Similar Publications